MedPath

Efficacy of Implant Surface Characteristics in Patients With History of Periodontitis

Not Applicable
Completed
Conditions
Marginal Bone Loss
Interventions
Procedure: Implant placement surgery
Registration Number
NCT05010382
Lead Sponsor
Universidad Complutense de Madrid
Brief Summary

The aim of the study is to evaluate in patients with history of periodontitis the clinical, microbiological and radiological outcomes of implants with a modified implant design consisting on a machined surface in the coronal third of the implant.

In this 12-month, parallel-arm, randomized controlled trial, patients with history of treated periodontitis and in need of dental implants for single-unit or short edentulous spaces (i.e. two implants) will be randomly assigned to a test group (implants with a hybrid surface, presenting a machined coronal third; HS) or a control group (conventional moderately rough implants; RS). Implants will be restored 3 months later with fixed implant supported reconstructions. Radiological, clinical, microbiological and patient-related outcome measures (PROMs) will be assessed 3, 6 and 12 months after the prosthetic installation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

•> 20 years of age

  • Presence of ≥1 adjacent missing teeth, in either maxilla or mandible (up to three missing units).
  • A natural tooth had to be present mesially to the most proximal implant site, although free end situations were allowed, and opposing dentition had to be natural teeth or implant supported fixed restorations.
  • History of treated and controlled periodontitis.
  • Presence of adequate bone volume to achieve primary implant stability without concomitant regeneration
Exclusion Criteria
  • Diseases affecting bone metabolism or wound healing (e.g.)
  • History of radiation therapy, leukocyte dysfunction, or any other immunodeficiency
  • Drug abuse
  • Intrasurgical exclusion criteria, such as the lack of primary stability, the need of bone augmentation or the impossibility of placing the implant based on prosthetic requirements. �

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Test groupImplant placement surgeryHybrid surface dental implant
Control groupImplant placement surgerymoderately rough surface implant
Primary Outcome Measures
NameTimeMethod
Radiographic marginal bone levels ChangeChange between baseline and 12 months

Radiographic marginal bone levels (bone loss) are defined as the distance between the bone crest and the implant shoulder at mesial and distal sites.

For standardization of periapical radiographs the same film holder-beam aiming device will be applied (Rinn System) and silicone custom-made bite blocks will be used to improve reproducible repositioning. All digital radiographs will be evaluated by one calibrated and trained researcher (BS) using a software (AutoCAD® Autodesk ®, California, USA) that allows to calibrate the distances using the known implant length.

Secondary Outcome Measures
NameTimeMethod
Microbiologic outcome measurements changeChange between baseline and 12 months

Paper points will be inserted to the depth of the peri-implant pocket and kept in place for 15 sec. The points will be transferred into a screw-capped vial, containing 1.5 ml of reduced transport fluid, (RTF) and maintained at -20ºC. Microbiological analysis by means of anaerobic culture will be performed for the determination of counts, proportion and frequency of detection of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Prevotella intermedia and Fusobacterium nucleatum.�

Clinical periodontal outcome measurements changeChange between baseline and 12 months

Clinical measurements will be performed at six sites per implant of i) probing depth (PD), ii) marginal mucosa recession assessed as length of the implant crown (CLI; distance from the mucosal margin to the oclusal surface at the mid buccal point), iii) bleeding on probing (BoP) and iv) plaque scores (PI). Finally, peri-implant mucositis, defined as the presence of profuse BoP.

Patient reported outcome measures (PROM's)changeChange between baseline and 12 months

PROM´s will be assessed by means of a questionnaire comprising 4 items: comfort, appearance, masticatory function and overall satisfaction. Patients will be asked to rate these four aspects according to the following scale: very unsatisfied, unsatisfied, fair, satisfied and very satisfied.

Trial Locations

Locations (1)

Facultad de odontología, Complutense University of Madrid

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath